The company has aggressively deleveraged its balance sheet, reducing total debt to $5.8 billion in 2026Q1 from $10.8 billion in 2023Q4, though retained earnings remain deeply negative at -$3.4 billion.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 5.44B | 5.59B | 7.99B | 6.29B | 7.43B | 6.99B | 3.06B | 2.94B | 2.94B | 1.9B | 1.61B | 1.44B | 1.71B | 1.65B | 1.57B | 1.32B | 1.33B | 1.13B | 1.16B | 1.19B | 1.08B | 1.19B | 961.37M | 902.67M | 866.75M | 896.36M | 1.02B | 835.4M | 848M | 935.5M | 1.01B |
| Cash & Short-Term Investments | 562M | 590M | 469M | 703M | 483M | 711M | 650M | 606.82M | 634.9M | 368.05M | 323.99M | 181.99M | 478.57M | 405.5M | 324.42M | 88.28M | 131.33M | 80.14M | 178.83M | 152.07M | 115.11M | 272.9M | 32.99M | 12.55M | 15.16M | 48.91M | 129.24M | 62.97M | 115M | 217M | 261.4M |
| Cash Only | 562M | 590M | 469M | 703M | 483M | 711M | 650M | 606.82M | 634.9M | 368.05M | 323.99M | 181.99M | 478.57M | 405.5M | 324.42M | 88.28M | 131.33M | 80.14M | 178.47M | 151.47M | 114.51M | 272.55M | 32.6M | 12.08M | 14.86M | 48.52M | 128.87M | 62.13M | 115M | 217M | 261.4M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 361K | 604K | 604K | 352K | 399K | 474K | 307K | 384K | 369K | 800K | 0 | 0 | 0 |
| Accounts Receivable | 1.83B | 2B | 1.97B | 2.09B | 2.16B | 2.21B | 1.12B | 1.02B | 1.21B | 879.05M | 693M | 683.07M | 635.02M | 673.4M | 641.84M | 630.45M | 451.8M | 444.26M | 439.77M | 450.58M | 405.3M | 304.82M | 358.36M | 339.73M | 338.61M | 340.36M | 332.22M | 303.42M | 283.5M | 268.5M | 269.4M |
| Days Sales Outstanding | 66.75 | 67.07 | 62.58 | 66.49 | 63.35 | 69.36 | 80.55 | 72.72 | 111.48 | 94.4 | 81.17 | 82.47 | 75.05 | 83.24 | 83.03 | 82.54 | 62.87 | 69.71 | 67.18 | 72.24 | 70.6 | 55.81 | 64.32 | 65.21 | 68.31 | 67.38 | 82.9 | 76.93 | 73.53 | 68.69 | 68.47 |
| Inventory | 2.25B | 2.36B | 2.26B | 2.64B | 3.3B | 2.52B | 1.13B | 1.12B | 1.08B | 649.45M | 592.02M | 572.05M | 568.73M | 533.81M | 540.66M | 544.44M | 531.67M | 444.98M | 479.57M | 484.22M | 446.61M | 430.79M | 457.2M | 454.63M | 421.6M | 415.98M | 435.31M | 415.27M | 404M | 360.1M | 369.1M |
| Days Inventory Outstanding | 123.05 | 114.74 | 111.88 | 123.48 | 145.27 | 115.94 | 137.82 | 135.42 | 171.54 | 123.06 | 125.57 | 124.91 | 120.24 | 116.76 | 119.9 | 118.05 | 126.82 | 116.69 | 123.4 | 133.45 | 134.58 | 134.51 | 143.83 | 151.9 | 148.56 | 142.78 | 208.43 | 206.11 | 206.38 | 181.82 | 184.3 |
| Other Current Assets | 795M | 257M | 3.1B | 677M | 1.35B | 1.26B | 56M | 77.88M | -263.41M | -215.39M | -142.35M | -145.18M | -113.54M | -108.72M | -76.64M | -104.05M | 74.16M | 55M | 23.7M | 24.66M | 89.45M | 182.76M | 79.27M | 66.07M | 67.18M | 77.45M | 122.17M | 53.76M | 45.5M | 89.9M | 106.5M |
| Total Non-Current Assets | 19.71B | 19.95B | 20.67B | 24.68B | 28.09B | 32.67B | 10.49B | 10.34B | 9.95B | 2.7B | 2.41B | 2.26B | 1.78B | 1.68B | 1.67B | 1.65B | 1.55B | 1.52B | 1.59B | 1.57B | 1.4B | 1.45B | 1.4B | 1.4B | 1.37B | 1.37B | 1.47B | 566.08M | 540.1M | 486.8M | 500.5M |
| Property, Plant & Equipment | 4B | 4.64B | 4.34B | 4.96B | 4.97B | 5.16B | 1.77B | 1.68B | 1.24B | 880.58M | 775.72M | 732.79M | 720.27M | 687.22M | 654.64M | 608.07M | 538.12M | 501.29M | 496.86M | 508.82M | 495.12M | 499.14M | 501.33M | 510.61M | 520.5M | 532.47M | 679.87M | 523.9M | 498.8M | 446.5M | 467.8M |
| Fixed Asset Turnover | 2.44x | 2.35x | 2.65x | 2.32x | 2.50x | 2.26x | 2.88x | 3.06x | 3.20x | 3.86x | 4.02x | 4.13x | 4.29x | 4.30x | 4.31x | 4.59x | 4.87x | 4.64x | 4.81x | 4.47x | 4.23x | 3.99x | 4.06x | 3.72x | 3.48x | 3.46x | 2.15x | 2.75x | 2.82x | 3.20x | 3.07x |
| Goodwill | 8.22B | 8.27B | 9.08B | 10.63B | 13.37B | 16.41B | 5.59B | 5.5B | 5.38B | 1.16B | 1B | 941.39M | 675.48M | 665.58M | 665.58M | 665.58M | 665.58M | 665.58M | 665.58M | 665.58M | 665.58M | 0 | 647.57M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 5.87B | 6.04B | 6.45B | 8.36B | 9.08B | 10.51B | 2.73B | 2.85B | 3.04B | 415.79M | 365.78M | 306M | 76.56M | 30.61M | 36.69M | 42.76M | 48.83M | 54.95M | 61.1M | 67.25M | 80.13M | 772.65M | 142.11M | 799.41M | 782.7M | 795.92M | 755.92M | 0 | 0 | 0 | 0 |
| Long-Term Investments | 303M | 15M | 10M | 11M | 10M | 86M | 5M | 0 | 31.47M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.62B | 693M | 560M | 449M | 490M | 427M | 208M | 190.2M | 168.2M | 149.95M | 127.71M | 118.39M | 129.24M | 140.98M | 159.52M | 179.83M | 171.93M | 165.16M | 204.65M | 219.48M | 75.88M | 175.13M | 110.91M | 94.19M | 62.74M | 43.3M | 34.3M | 42.16M | 41.3M | 40.3M | 32.7M |
| Total Assets | 25.14B | 25.54B | 28.67B | 30.98B | 35.52B | 39.66B | 13.56B | 13.29B | 12.89B | 4.6B | 4.02B | 3.7B | 3.49B | 3.33B | 3.25B | 2.97B | 2.87B | 2.64B | 2.75B | 2.73B | 2.48B | 2.64B | 2.36B | 2.31B | 2.23B | 2.27B | 2.49B | 1.4B | 1.39B | 1.42B | 1.51B |
| Asset Turnover | 0.42x | 0.43x | 0.40x | 0.37x | 0.35x | 0.29x | 0.38x | 0.39x | 0.31x | 0.74x | 0.78x | 0.82x | 0.88x | 0.89x | 0.87x | 0.94x | 0.91x | 0.88x | 0.87x | 0.83x | 0.85x | 0.76x | 0.86x | 0.82x | 0.81x | 0.81x | 0.59x | 1.03x | 1.01x | 1.00x | 0.95x |
| Asset Growth % | -47.44% | -10.91% | -7.46% | -12.79% | -10.43% | 192.56% | 2.02% | 3.09% | 180.27% | 14.49% | 8.51% | 5.93% | 4.89% | 2.53% | 9.58% | 3.24% | 8.61% | -3.82% | 0.85% | 10% | -6.04% | 11.63% | 2.44% | 3.32% | -1.56% | -8.88% | 77.6% | 0.97% | -2.4% | -5.61% | -1.79% |
| Total Current Liabilities | 3.65B | 3.93B | 4.33B | 3.76B | 3.73B | 3.63B | 1.9B | 1.55B | 1.13B | 768.77M | 898.3M | 725.16M | 518.81M | 560.37M | 629.88M | 564.57M | 660.95M | 484.45M | 451.04M | 543.44M | 446.77M | 1.2B | 399.52M | 526.04M | 359.5M | 560.21M | 1.18B | 369.7M | 272.9M | 264.9M | 280.5M |
| Accounts Payable | 1.37B | 1.29B | 1.28B | 1.38B | 1.42B | 1.53B | 556M | 510.37M | 471.38M | 338.19M | 274.81M | 285.5M | 216.04M | 226.73M | 199.27M | 208.76M | 200.15M | 161.03M | 115M | 130.99M | 111.66M | 98.59M | 103.98M | 104.03M | 104.01M | 85.66M | 75.02M | 71.99M | 60.3M | 57.8M | 57.7M |
| Days Payables Outstanding | 68.95 | 62.47 | 63.63 | 64.5 | 62.44 | 70.59 | 67.69 | 61.54 | 74.97 | 64.08 | 58.29 | 62.34 | 45.68 | 49.59 | 44.19 | 45.26 | 47.74 | 42.23 | 29.59 | 36.1 | 33.65 | 30.78 | 32.71 | 34.76 | 36.65 | 29.4 | 35.92 | 35.73 | 30.8 | 29.18 | 28.81 |
| Short-Term Debt | 1.08B | 1.36B | 1.41B | 885M | 597M | 632M | 634M | 384.96M | 48.64M | 6.97M | 258.52M | 132.35M | 8.09M | 149K | 150.07M | 116.69M | 133.9M | 76.78M | 101.98M | 152.47M | 15.9M | 819.39M | 15.96M | 194.3M | 49.66M | 227.94M | 852.99M | 92.47M | 29.1M | 10.5M | 18.9M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 983M | 647M | 485M | 156M | 313M | 226M | 115M | 266.3M | 241.4M | 176.94M | 129.31M | 175.03M | 146.63M | 149.99M | 144.57M | 127.43M | 287.69M | 208.87M | 137.96M | 131.96M | 247.24M | 261.46M | 226.13M | 227.71M | 169.58M | 207.38M | 251.01M | 205.24M | 183.5M | 196.6M | 203.9M |
| Current Ratio | 1.49x | 1.42x | 1.84x | 1.67x | 1.99x | 1.92x | 1.61x | 1.90x | 2.61x | 2.47x | 1.79x | 1.98x | 3.30x | 2.95x | 2.50x | 2.33x | 2.00x | 2.33x | 2.57x | 2.19x | 2.42x | 0.99x | 2.41x | 1.72x | 2.41x | 1.60x | 0.86x | 2.26x | 3.11x | 3.53x | 3.59x |
| Quick Ratio | 0.87x | 0.82x | 1.32x | 0.97x | 1.11x | 1.23x | 1.01x | 1.17x | 1.65x | 1.62x | 1.13x | 1.19x | 2.20x | 2.00x | 1.64x | 1.37x | 1.20x | 1.41x | 1.51x | 1.30x | 1.42x | 0.63x | 1.26x | 0.85x | 1.24x | 0.86x | 0.50x | 1.14x | 1.63x | 2.17x | 2.27x |
| Cash Conversion Cycle | 120.85 | 119.34 | 110.83 | 125.46 | 146.18 | 114.7 | 150.68 | 146.6 | 208.05 | 153.38 | 148.45 | 145.04 | 149.61 | 150.41 | 158.74 | 155.32 | 141.95 | 144.17 | 160.99 | 169.59 | 171.53 | 159.54 | 175.44 | 182.35 | 180.22 | 180.76 | 255.41 | 247.31 | 249.1 | 221.32 | 223.96 |
| Total Non-Current Liabilities | 7.35B | 7.42B | 10.42B | 12.58B | 14.05B | 14.8B | 5.23B | 5.41B | 5.64B | 2.14B | 1.49B | 1.38B | 1.45B | 1.3B | 1.36B | 1.29B | 1.21B | 1.39B | 1.73B | 1.57B | 1.13B | 520.15M | 1.05B | 1.04B | 1.3B | 1.18B | 678.76M | 173.3M | 170.1M | 156.9M | 149.9M |
| Long-Term Debt | 4.74B | 4.74B | 7.56B | 9.19B | 10.37B | 10.77B | 3.78B | 4B | 4.5B | 1.63B | 1.07B | 935.37M | 934.23M | 932.66M | 881.1M | 778.25M | 787.67M | 934.75M | 1.15B | 1.06B | 791.44M | 131.28M | 668.97M | 690.23M | 1.01B | 939.4M | 417.4M | 3.83M | 4.3M | 5.1M | 8.3M |
| Capital Lease Obligations | 1.67B | 553M | 534M | 642M | 672M | 670M | 265M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 5.46B | 1.38B | 1.59B | 1.94B | 2.28B | 2.52B | 593M | 641.46M | 655.88M | 51.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44.55M | 103.15M | 32.78M | 30.7M | 23.1M | 16.9M |
| Other Non-Current Liabilities | 1.25B | 748M | 733M | 813M | 722M | 847M | 594M | 767.74M | 444.24M | 420.23M | 380.88M | 403.23M | 472.36M | 330.31M | 437.98M | 467.5M | 369.76M | 398.78M | 513.46M | 443.85M | 335.52M | 388.87M | 384.32M | 347.99M | 291.43M | 199.71M | 158.2M | 136.68M | 135.1M | 128.7M | 124.7M |
| Total Liabilities | 10.99B | 11.35B | 14.76B | 16.34B | 17.78B | 18.44B | 7.14B | 6.96B | 6.76B | 2.91B | 2.39B | 2.11B | 1.97B | 1.86B | 2B | 1.86B | 1.87B | 1.87B | 2.18B | 2.11B | 1.57B | 1.72B | 1.45B | 1.56B | 1.66B | 1.74B | 1.86B | 543M | 443M | 421.8M | 430.4M |
| Total Debt | 5.82B | 6.65B | 9.62B | 10.82B | 11.74B | 12.2B | 4.73B | 4.68B | 4.55B | 1.64B | 1.33B | 1.07B | 942.32M | 925.72M | 1.02B | 883.97M | 921.57M | 1.01B | 1.26B | 1.21B | 807.34M | 950.67M | 684.93M | 884.53M | 1.06B | 1.17B | 1.27B | 96.3M | 33.4M | 15.6M | 27.2M |
| Net Debt | 5.25B | 6.06B | 9.15B | 10.11B | 11.25B | 11.48B | 4.07B | 4.05B | 3.9B | 1.27B | 1B | 885.73M | 463.75M | 520.22M | 697.73M | 795.69M | 790.24M | 931.39M | 1.08B | 1.06B | 692.83M | 678.13M | 652.33M | 872.45M | 1.04B | 1.12B | 1.14B | 34.2M | -81.6M | -201.4M | -234.2M |
| Debt / Equity | 0.41x | 0.47x | 0.69x | 0.74x | 0.66x | 0.57x | 0.74x | 0.74x | 0.74x | 0.97x | 0.81x | 0.67x | 0.62x | 0.63x | 0.82x | 0.80x | 0.92x | 1.31x | 2.19x | 1.96x | 0.89x | 1.04x | 0.75x | 1.19x | 1.84x | 2.23x | 2.01x | 0.11x | 0.04x | 0.02x | 0.03x |
| Debt / EBITDA | 3.35x | 3.39x | 5.40x | - | - | 7.01x | 5.30x | 4.73x | 6.01x | 2.44x | 2.02x | 1.57x | 1.38x | 1.54x | 1.81x | 1.71x | 1.86x | 2.42x | 2.91x | 2.71x | 1.93x | 2.65x | 1.71x | 2.37x | 2.67x | 2.85x | 3.86x | 0.29x | 0.09x | 0.04x | 0.07x |
| Net Debt / EBITDA | 3.03x | 3.09x | 5.14x | - | - | 6.60x | 4.57x | 4.10x | 5.15x | 1.90x | 1.53x | 1.31x | 0.68x | 0.87x | 1.24x | 1.54x | 1.59x | 2.22x | 2.50x | 2.37x | 1.65x | 1.89x | 1.63x | 2.34x | 2.63x | 2.73x | 3.47x | 0.10x | -0.23x | -0.53x | -0.60x |
| Interest Coverage | 5.26x | -0.80x | 1.91x | -5.63x | -3.84x | 2.22x | 4.34x | 5.04x | 4.38x | 9.22x | 10.88x | 12.70x | 12.92x | 11.38x | 11.62x | 9.37x | 8.38x | 5.47x | 4.84x | 8.91x | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 14.15B | 14.19B | 13.91B | 14.64B | 17.74B | 21.22B | 6.42B | 6.33B | 6.13B | 1.69B | 1.63B | 1.59B | 1.52B | 1.47B | 1.25B | 1.11B | 1B | 771.91M | 573.11M | 617.2M | 905.17M | 915.35M | 910.49M | 742.63M | 574.68M | 524.17M | 631.26M | 858.5M | 945.1M | 1B | 1.08B |
| Equity Growth % | 6.48% | 1.98% | -4.99% | -17.48% | -16.39% | 230.53% | 1.45% | 3.32% | 262.59% | 3.57% | 2.27% | 4.75% | 3.79% | 17.12% | 13.11% | 10.39% | 29.96% | 34.69% | -7.14% | -31.81% | -1.11% | 0.53% | 22.6% | 29.23% | 9.64% | -16.96% | -26.47% | -9.16% | -5.54% | -7.06% | -3.59% |
| Book Value per Share | 55.07 | 55.41 | 54.34 | 57.42 | 69.58 | 87.33 | 56.50 | 55.85 | 69.51 | 21.28 | 20.39 | 19.72 | 18.68 | 17.91 | 15.31 | 13.59 | 12.47 | 9.76 | 7.19 | 7.04 | 9.91 | 9.67 | 9.52 | 7.87 | 6.01 | 5.42 | 6.26 | 8.11 | 8.81 | 9.12 | 9.64 |
| Total Shareholders' Equity | 14.12B | 14.15B | 13.88B | 14.61B | 17.66B | 21.08B | 6.31B | 6.22B | 6.03B | 1.68B | 1.63B | 1.59B | 1.52B | 1.46B | 1.25B | 1.1B | 999.42M | 769M | 573.11M | 617.2M | 905.17M | 915.35M | 910.49M | 742.63M | 574.68M | 524.17M | 631.26M | 858.5M | 945.1M | 1B | 1.08B |
| Common Stock | 35M | 35M | 35M | 35M | 35M | 35M | 16.07M | 16.07M | 16.07M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.47M | 14.5M | 0 | 0 | 0 |
| Retained Earnings | -3.35B | -3.42B | -2.6B | -2.44B | 955M | 3.64B | 4.16B | 4.12B | 3.96B | 3.87B | 3.82B | 3.6B | 3.35B | 3.08B | 2.84B | 2.69B | 2.52B | 2.34B | 2.22B | 2.08B | 1.91B | 1.75B | 1.63B | 1.5B | 1.38B | 1.26B | 1.2B | 1.21B | 1.21B | 1.17B | 1.11B |
| Treasury Stock | -986M | -952M | -944M | -963M | -978M | -997M | -1.02B | -1.02B | -1.03B | -1.73B | -1.68B | -1.56B | -1.45B | -1.37B | -1.33B | -1.36B | -1.38B | -1.42B | -1.44B | -1.39B | -918.66M | -772.72M | -701.83M | -727.45M | -712.88M | -698.85M | -643.24M | -445.11M | 0 | 0 | 0 |
| Accumulated OCI | -1.51B | -1.43B | -2.53B | -1.9B | -2.2B | -1.42B | -697.54M | -716.89M | -702.23M | -637.48M | -680.1M | -613.44M | -540.43M | -392.71M | -403.63M | -375.31M | -275.35M | -270.97M | -325.11M | -144.35M | -196.87M | -150.35M | -109.04M | -135.63M | -219.19M | -180.96M | -77.58M | -57.1M | -414.6M | -364.4M | -410.4M |
| Minority Interest | 33M | 32M | 35M | 31M | 89M | 140M | 109.43M | 111.29M | 92.23M | 5.09M | 4.89M | 4.67M | 4.13M | 3.98M | 3.75M | 3M | 3.73M | 2.91M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
High leverage and divestiture
As reported in financial statements, IFF's total assets have declined from $31.0 billion in 2023Q4 to $25.1 billion in 2026Q1, signaling a deliberate, albeit painful, effort to shrink the balance sheet through divestitures and asset impairment charges following the aggressive DuPont Nutrition & Biosciences acquisition.
The reduction in total assets suggests that management is actively pruning the portfolio to address the over-leveraged position created by previous M&A activity. Investors should monitor whether this contraction represents a permanent shift toward a leaner, more focused business model or if it indicates an inability to sustain the scale required for global sensory leadership.
Based on IFF's reported figures, total debt has been reduced from $10.8 billion in 2023Q4 to $5.8 billion in 2026Q1, indicating that the company is prioritizing debt repayment as a primary capital allocation strategy to mitigate the risks associated with its previous acquisition-heavy growth phase.
While the absolute reduction in debt is a positive development, the persistent negative retained earnings suggest that the company is still absorbing the financial impact of past strategic missteps. The reliance on divestiture proceeds to pay down debt warrants further investigation into the long-term viability of the remaining core business segments.
According to recent SEC filings, IFF's goodwill balance has decreased from $10.6 billion in 2023Q4 to $8.2 billion in 2026Q1, which may indicate that the company is finally recognizing the overpayment for past acquisitions through necessary, yet significant, non-cash impairment charges against its asset base.
The high concentration of goodwill relative to total assets suggests that the balance sheet remains sensitive to future valuation adjustments if the acquired business units fail to meet performance expectations. This intangible-heavy asset mix implies that the company's book value may not fully reflect the current economic reality of its operational segments.
As evidenced by the 2026Q1 current ratio of 1.49, IFF maintains a sufficient liquidity buffer to meet its near-term obligations, though the cash position of $562 million appears relatively thin compared to the company's historical debt service requirements and ongoing operational restructuring needs.
The fluctuation in the current ratio over the last ten quarters suggests that working capital management remains a challenge, likely exacerbated by the volatility in raw material costs and inventory cycles. Investors should monitor whether the company can maintain this liquidity profile without further relying on non-core asset sales.
Based on reported financial statements, IFF's retained earnings have remained deeply negative, sitting at -$3.4 billion in 2026Q1, which highlights the cumulative impact of integration costs and operational losses that have significantly eroded the company's equity base over the past several fiscal periods.
The persistent deficit in retained earnings suggests that the company has struggled to generate organic profitability sufficient to offset the costs of its strategic transformation. This trend may indicate that the equity base is currently supported more by historical capital contributions than by the successful compounding of internal earnings.
Quick answers to the most common questions about buying IFF stock.
As of 2025, International Flavors & Fragrances Inc. (IFF) had total assets of $25.54B including $5.59B in current assets.
International Flavors & Fragrances Inc. (IFF) carries total debt of $6.65B, offset by $590.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
International Flavors & Fragrances Inc. (IFF) has total shareholders' equity (book value) of $14.15B ($55.41 book value per share). Book value represents the net worth of the company belonging to common stock holders.
International Flavors & Fragrances Inc. (IFF) reported a current ratio of 1.42x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.